Litigation Details for Actelion Pharmaceuticals US, Inc. v. Lannett Company, Inc. (D. Del. 2024)
✉ Email this page to a colleague
Actelion Pharmaceuticals US, Inc. v. Lannett Company, Inc. (D. Del. 2024)
Docket | ⤷ Sign Up | Date Filed | 2024-10-18 |
Court | District Court, D. Delaware | Date Terminated | |
Cause | 35:271 Patent Infringement | Assigned To | |
Jury Demand | None | Referred To | |
Patents | 8,791,122; 9,284,280 | ||
Link to Docket | External link to docket |
Small Molecule Drugs cited in Actelion Pharmaceuticals US, Inc. v. Lannett Company, Inc.
Details for Actelion Pharmaceuticals US, Inc. v. Lannett Company, Inc. (D. Del. 2024)
Date Filed | Document No. | Description | Snippet | Link To Document |
---|---|---|---|---|
2024-10-17 | 4 | Patent/Trademark Report to Commissioner of Patents | the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 8,791,122; 9,284,280. (scs) (… 18 October 2024 1:24-cv-01162 835 Patent - Abbreviated New Drug Application(ANDA) None | External link to document |
>Date Filed | >Document No. | >Description | >Snippet | >Link To Document |